Parb Pharmaceuticals Private Limited

Parb Pharmaceuticals Private Limited - food and beverages in Dehradun, Uttarakhand, India. Directors, charges & compliance details.
CIN U24304UR2022PTC014870 Incorporated 16 November 2022 ROC Uttarakhand HQ Dehradun, Uttarakhand, India
Active Private Limited Company food and beverages MSME
Data last updated
Revenue · FY 2025
₹59.42 Cr
▲ 2461% YoY
Net profit · FY 2025
₹8.33 Cr
Net margin 14%
EBITDA · FY 2025
₹10.77 Cr
EBITDA margin 18.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
3
As per MCA filings
Active GSTINs
1
of 2 registered

About Parb Pharmaceuticals Private Limited

Data last updated:

Parb Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 16 November 2022.

The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24304UR2022PTC014870. Its GSTIN is 05AANCP3666K1ZX (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1 Lakh. It is led by directors including Konic Goyal and Anuj Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dehradun, Uttarakhand.

As per the financials filed for FY 2025, the company reported a revenue of ₹59.42 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.33 Cr (net margin 14%) and EBITDA of ₹10.77 Cr (EBITDA margin 18.1%).

Parb Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-UK-05-0037042). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24304UR2022PTC014870
Registration Number 014870
Incorporation Date 16 November 2022
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-UK-05-0037042

Recognitions & Rankings of Parb Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-UK-05-0037042

Contact details

Parb Pharmaceuticals Private Limited's registered office is in Dehradun, Uttarakhand.

  • Registered Address
    E – 9 Sector – Sidc, Iie Selaqui, Dehradun, Uttarakhand, India – 248011
  • Industry
    Food And Beverages, Manufacturing, Artificial Fibres
Comprehensive company report
Parb Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Parb Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Parb Pharmaceuticals Private Limited, buy the company report.

Financials of Parb Pharmaceuticals Private Limited

FY 2025 filings available

Parb Pharmaceuticals Private Limited reported revenue of ₹59.42 Cr (up 2461% YoY) for FY 2025.

Revenue · FY 2025
₹59.42 Cr ▲ 2461%
Net profit · FY 2025
₹8.33 Cr margin 14%
EBITDA · FY 2025
₹10.77 Cr margin 18.1%

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.77 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8.33 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin18.1%
Net Profit Margin14%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Parb Pharmaceuticals Private Limited, buy the company report.

Board of directors of Parb Pharmaceuticals Private Limited

Parb Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Anuj KumarAdditional Director29 Aug 20233 Years 2 MonthsCurrent
Manic GoyalAdditional Director23 Sep 20233 Years 1 MonthsCurrent
Konic GoyalDirector16 Nov 20223 Years 11 MonthsCurrent

Peer comparison

Parb Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Arbro Pharmaceuticals Private Limited₹64.16 Cr (FY 2025)-9.0%Delhi, India
MDC Pharmaceuticals Limited₹61.89 Cr (FY 2024)14.0%Chandigarh, India
Lok-Beta Pharmaceuticals (India )Private Limited₹60.2 Cr (FY 2024)40.0%Mumbai, Maharashtra, India
Parb Pharmaceuticals Private Limitedthis company₹59.42 Cr (FY 2025)₹8.33 Cr14%2461.0%Dehradun, Uttarakhand, India
Vaasavaa Pharmaceuticals Private Limited₹59.28 Cr (FY 2025)16.0%Solapur, Maharashtra, India
Solistaa Pharmaceuticals Private Limited₹57.79 Cr (FY 2025)8.0%Puducherry, India
Stedman Pharmaceuticals Private Limited₹57.77 Cr (FY 2024)9.0%Chennai, Tamil Nadu, India
Accretion Pharmaceuticals Limited₹57.47 Cr (FY 2025)329.0%Sanand, Gujarat, India
Alidac Pharmaceuticals Limited₹57.16 Cr (FY 2019)-60.0%Matoda, Gujarat, India

To see the full peer comparison of Parb Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Parb Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Parb Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
05AANCP3666K1ZXUttarakhandActive27 Dec 2022

To see the full GST registrations and return filing status of Parb Pharmaceuticals Private Limited, buy the company report.

Recent activity

Parb Pharmaceuticals Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Manic Goyal was appointed as Additional Director on 23 Sep 2023.

AGM
Parb Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Parb Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Appointed
Manic Goyal was appointed as Additional Director.
Ceased
Parshotam Lal Goyal ceased to be Director.
Appointed
Anuj Kumar was appointed as Additional Director.
Appointed
Konic Goyal was appointed as Director.
Incorporation
16 Nov 2022
Parb Pharmaceuticals Private Limited was registered on 16 Nov 2022 with Roc Uttarakhand & aged 3 years 11 months as per MCA records.

Frequently asked questions

Parb Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 16 November 2022 (4+ years old) and is registered under CIN U24304UR2022PTC014870.

Parb Pharmaceuticals has 3 current directors:

The latest financial statements of Parb Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Parb Pharmaceuticals is 05AANCP3666K1ZX, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Parb Pharmaceuticals is U24304UR2022PTC014870. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Parb Pharmaceuticals was incorporated on 16 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttarakhand.

The peers of Parb Pharmaceuticals by revenue are Arbro Pharmaceuticals Private Limited, MDC Pharmaceuticals Limited, Lok-Beta Pharmaceuticals (India )Private Limited, Vaasavaa Pharmaceuticals Private Limited, Solistaa Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Manic Goyal was appointed as Additional Director on 23 Sep 2023. Parshotam Lal Goyal ceased to be Director on 21 Sep 2023. Anuj Kumar was appointed as Additional Director on 29 Aug 2023. Parb Pharmaceuticals has 4 board changes on record in total.

Yes, Parb Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-UK-05-0037042).

The registered office of Parb Pharmaceuticals is at E – 9 Sector – Sidc, Iie Selaqui, Dehradun, Uttarakhand, India – 248011.

Parb Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.